Dr. Jasreman Dhillon, MD

Dr. Dhillon practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Dhillon's NPI, 1073800447, was assigned on July 6, 2011. Dr. Dhillon graduated from Government Medical College Chandigrah in 1998. Dr. Dhillon holds Florida license ME109962.

Dr. Dhillon's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Dhillon's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Dhillon is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Dhillon to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhillon practices, 5 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Dhillon's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Dhillon is board certified in cytopathology by the American Board of Pathology. Dmand AI has Dr. Dhillon's licenses on file in 2 states: Florida and Texas.

CMS data shows 1,162 Medicare services from Dr. Dhillon across 13 procedure codes in 2024, for 575 Medicare patients. Medicare paid $51,254 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 575 Medicare patients who saw Dr. Dhillon in 2024. The largest group is 65 to 74, with 312 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhillon's median patient age at 70, with 12% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Dhillon for performance year 2024, reported as part of a group. Dr. Dhillon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 89 papers to Dr. Dhillon, published from 2009 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Biomarkers, Tumor, Prostatic Neoplasms and Kidney Neoplasms. Dr. Dhillon has published most often in Cancers (Basel). Dr. Dhillon's most frequent co-authors are Philippe E. Spiess, MD, Julio M. Pow-Sang, MD and Wade J. Sexton, MD.

Dmand AI links Dr. Dhillon to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 6 general payments to Dr. Dhillon from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $125.

Dr. Dhillon graduated from Government Medical College Chandigrah in 1998.

Dr. Dhillon is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.